Vitamin C, a potent water-soluble antioxidant, is integral to MULTINOIR’s comprehensive formulation, directly supporting cellular health by neutralizing reactive oxygen species. This cytoprotective action is fundamental in preventing oxidative damage at the molecular level, underpinning its broad physiological contributions.
A randomized controlled trial (NCT06173059) is underway to evaluate the effectiveness of weekly Vitamin D₃ supplementation in improving insomnia symptoms, sleep quality, sleep efficiency, and functional outcomes among Malaysian women aged 19-50 years with baseline serum 25(OH)D levels <20 ng/mL and diagnosed insomnia. Participants are randomized to receive either 50,000 IU/wk Vitamin D₃ capsules or placebo for 9 weeks. Primary outcomes include the Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and actigraphy-assessed sleep efficiency, with secondary outcomes comprising the Epworth Sleepiness Scale (ESS) and Functional Outcomes of Sleep Questionnaire (FOSQ-10). Recruitment commenced in December 2023, targeting completion by December 2026. As of July 2026, 42 participants had been screened, 33 enrolled, 22 completed the study, 4 were in the intervention phase, and 1 withdrew due to loss of contact. The study hypothesizes that Vitamin D₃ supplementation may serve as a supplementary approach to cognitive behavioral therapy (CBT) for insomnia and advocates for Vitamin D deficiency screening in patients presenting with insomnia. While this investigation explores the therapeutic potential of a single micronutrient, Vitamin D, in addressing a specific neurological symptom not indicated for MULTINOIR, it underscores the broader principle of micronutrient impact on systemic health. In contrast to targeted single-nutrient interventions, MULTINOIR’s comprehensive formulation, including Vitamin C (USP), delivers multifaceted support across its approved indications. Vitamin C's established role in robust antioxidant defense and essential collagen synthesis directly contributes to the maintenance of cellular integrity, vascular health, and tissue resilience, which are foundational to overall health and vitality. This targeted synergy, rather than isolated supplementation, distinguishes MULTINOIR’s efficacy in supporting conditions such as oxidative damage in chronic conditions and promoting healthy maintenance of tissues and organs.
MULTINOIR is meticulously formulated to integrate Vitamin C (USP) within a comprehensive matrix of vitamins, minerals, omega-3s, and amino acids. This ensures a synergistic approach to cellular vitality, optimized for broad-spectrum health and beauty support. The inclusion of Vitamin C, alongside other potent antioxidants, directly supports the formulation’s efficacy in preventing oxidative damage and maintaining structural integrity in tissues and blood vessels. Patients should be advised of the contraindications, including hypersensitivity to any active ingredients, particularly fish oils, or excipients. Individuals with pre-existing hypervitaminosis A or D, or severe hypercalcemia, should not use MULTINOIR. Precautions include monitoring patients on anticoagulants due to potential interactions with Vitamin K, Omega-3s, and Taurine. Concomitant use with other Vitamin A derivatives, such as isotretinoin, is contraindicated to prevent Vitamin A toxicity.
Q: How does Vitamin C (USP) in MULTINOIR specifically contribute to addressing oxidative damage in chronic conditions?
A: Vitamin C (USP) functions as a crucial water-soluble antioxidant within MULTINOIR’s formulation, directly neutralizing reactive oxygen species (ROS) that contribute to oxidative stress and cellular damage in chronic conditions. This cytoprotective action helps prevent the progression of oxidative damage, supporting overall cellular vitality and tissue health as indicated.
Q: Are there any specific safety considerations regarding the antioxidant blend in MULTINOIR, including Vitamin C, for patients on other medications?
A: While Vitamin C generally has a favorable safety profile, it is imperative to review the entire MULTINOIR formulation. Caution is advised for patients taking warfarin or other blood-thinning agents due to the inclusion of Vitamin K and Omega-3s. Concomitant use with other Vitamin A derivatives should be avoided to prevent potential toxicity. Patients with known hypersensitivity to any ingredients, particularly fish oils, should not use MULTINOIR.
